Intracranial Vasculopathy in a Patient with Systemic Sclerosis: Atherosclerotic or Moyamoya-Like Disease?
Han Na Choi, Si Hye Kim, Hyun Hee Kim, Seong-Kyu Kim, Jung-Yoon Choe, Sung-Hoon Park
Korean J Intern Med. 2012;27(2):239-242. Published online 2012 May 31 DOI: https://doi.org/10.3904/kjim.2012.27.2.239
Citations to this article as recorded by 
Routine screening serum tests to detect underlying thyroid and autoimmune diseases in patients with moyamoya disease
Kei Ito, Shoko Hara, Motoki Inaji, Junshi Cho, Masanori Murakami, Tetsuya Yamada, Tadashi Nariai, Takethosi Maehara
Clinical Neurology and Neurosurgery.2024; 243: 108403. CrossRef
Neuroimaging findings in rheumatologic disorders
Sedat Giray Kandemirli, Girish Bathla
Journal of the Neurological Sciences.2021; 427: 117531. CrossRef
Systemic sclerosis associated with moyamoya syndrome: A case report and literature review
Haifeng Chen, Xinyu Jiang, Yitian Shi, Fenghong Yuan, Zhigang Hu
Immunobiology.2020; 225(2): 151882. CrossRef
Reply to ‘Moyamoya vasculopathy with anti-SCL-70 antibodies: A case report and review of the literature’
Franz Wegner, Ulf Müller-Ladner, Florian MP Meier
Journal of Clinical Neuroscience.2019; 63: 281. CrossRef
Moyamoya vasculopathy with anti-SCL-70 antibodies: A case report and review of the literature
Ayesha S. Ahmad, Rizwan A. Tahir, Panayiotis D. Mitsias
Journal of Clinical Neuroscience.2018; 56: 177. CrossRef
Neurologic involvement in scleroderma: A systematic review
Tiago Nardi Amaral, Fernando Augusto Peres, Aline Tamires Lapa, João Francisco Marques-Neto, Simone Appenzeller
Seminars in Arthritis and Rheumatism.2013; 43(3): 335. CrossRef